Clinical trials Tucidinostat, a promising therapeutic option for R/R peripheral T-cell lymphoma Read more
Clinical trials Ide-cel outperforms standard regimens in triple-class-exposed R/R multiple myeloma Read more
Clinical trials Dabrafenib plus trametinib induces durable responses in BRAF-mutated hairy cell leukaemia Read more
Clinical trials Efficacy and safety of emicizumab demonstrated in people with mild or moderate haemophilia A Read more
Clinical trials Adding daratumumab to bortezomib-dexamethasone improves survival in myeloma patients Read more
Clinical trials G-CSF, decitabine and busulfan-cyclophosphamide conditioning for MDS and secondary AML Read more
Clinical trials KRd regimen after stem cell transplantation delays disease progression in multiple myeloma Read more
Clinical trials Enasitenib outperforms conventional care in pretreated older IDH2-mutant R/R AML patients Read more
